Psychemedics Corporation (NASDAQ:PMD) VP Michael I. Schaffer sold 7,548 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $20.41, for a total value of $154,054.68. Following the transaction, the vice president now directly owns 41,273 shares in the company, valued at $842,381.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Psychemedics Corporation (NASDAQ PMD) opened at 18.69 on Friday. The stock’s 50 day moving average price is $21.97 and its 200-day moving average price is $21.61. The company has a market capitalization of $102.63 million, a P/E ratio of 13.79 and a beta of 1.02. Psychemedics Corporation has a one year low of $13.81 and a one year high of $27.99.

Psychemedics Corporation (NASDAQ:PMD) last announced its earnings results on Wednesday, August 2nd. The company reported $0.16 earnings per share for the quarter. Psychemedics Corporation had a return on equity of 47.94% and a net margin of 17.59%. The firm had revenue of $9.68 million for the quarter. Equities analysts forecast that Psychemedics Corporation will post $0.93 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 24th. Investors of record on Monday, August 14th were paid a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, August 10th. This represents a $0.60 annualized dividend and a yield of 3.21%. Psychemedics Corporation’s dividend payout ratio (DPR) is 44.44%.

TRADEMARK VIOLATION NOTICE: This story was first reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/psychemedics-corporation-pmd-vp-sells-154054-68-in-stock/1550129.html.

A number of hedge funds have recently made changes to their positions in PMD. Mountain Capital Investment Advisors Inc purchased a new position in Psychemedics Corporation during the 2nd quarter worth $136,000. Connors Investor Services Inc. grew its stake in Psychemedics Corporation by 13.3% during the 2nd quarter. Connors Investor Services Inc. now owns 11,902 shares of the company’s stock worth $297,000 after buying an additional 1,400 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Psychemedics Corporation by 14.2% during the 2nd quarter. Janney Montgomery Scott LLC now owns 14,218 shares of the company’s stock worth $355,000 after buying an additional 1,767 shares during the last quarter. Carl Domino Inc grew its stake in Psychemedics Corporation by 0.6% during the 2nd quarter. Carl Domino Inc now owns 14,485 shares of the company’s stock worth $361,000 after buying an additional 92 shares during the last quarter. Finally, Gs Investments Inc. purchased a new position in Psychemedics Corporation during the 2nd quarter worth $387,000. Hedge funds and other institutional investors own 57.93% of the company’s stock.

Psychemedics Corporation Company Profile

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.

Insider Buying and Selling by Quarter for Psychemedics Corporation (NASDAQ:PMD)

Receive News & Ratings for Psychemedics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.